Tumor necrosis factor α in the onset and progression of leukemia

Slides:



Advertisements
Similar presentations
What We Talk About When We Talk About Fat Evan D. Rosen, Bruce M. Spiegelman Cell Volume 156, Issue 1, Pages (January 2014) DOI: /j.cell
Advertisements

Oxidative stress and hypoxia in normal and leukemic stem cells Ugo Testa, Catherine Labbaye, Germana Castelli, Elvira Pelosi Experimental Hematology Volume.
GSK3β inhibition activates the CDX/HOX pathway and promotes hemogenic endothelial progenitor differentiation from human pluripotent stem cells Kenji Kitajima,
Experimental Hematology
Alexander Loewer, Galit Lahav  Cell 
Susanne Wingert, Michael A. Rieger  Experimental Hematology 
Smac Mimetics and TNFα: A Dangerous Liaison?
High-mobility group box-1 protein induces osteogenic phenotype changes in aortic valve interstitial cells  Bo Wang, PhD, Fei Li, MD, Chao Zhang, PhD,
The CD70-CD27 Axis, a New Brake in the T Helper 17 Cell Response
Immunologic pathomechanism of Hodgkin's lymphoma
Positioning NK-κB in multiple myeloma
Connecting COX-2 and Wnt in cancer
Ling Guo, Robert C.H. Zhao, Yaojiong Wu  Experimental Hematology 
D.H. Dockrell  Clinical Microbiology and Infection 
Nishitha M. Reddy, Olalekan Oluwole, John P. Greer, Brian G
The Taming of the NF-κB: PP4R1 Navigates while PP4c Dephosphorylates
Nomeda Girnius, Roger J. Davis  Cancer Cell 
Cassie J. Clarke, Tessa L. Holyoake  Experimental Hematology 
Jean-Charles Nault, Jessica Zucman-Rossi  Journal of Hepatology 
Immunologic pathomechanism of Hodgkin's lymphoma
Granulocyte colony-stimulating factor receptor signaling in severe congenital neutropenia, chronic neutrophilic leukemia, and related malignancies  Pankaj.
Volume 120, Issue 1, Pages (January 2001)
From mesothelioma to cardiovascular protection via the phosphoinositide-3 kinase pathway: A new vista in cardiothoracic surgery  Igor E. Konstantinov,
Tumor Evolution: A Problem of Histocompatibility
Personalizing Therapy for Colorectal Cancer
Velizar Shivarov, Lars Bullinger  Experimental Hematology 
A Radical Role for p38 MAPK in Tumor Initiation
Innate immunity as a driving force in renal disease
TNF-α–induced protein 3 (A20): The immunological rheostat
Ya-Huei Kuo, Jing Qi, Guerry J. Cook  Experimental Hematology 
Kaitlin A. Read, Michael D. Powell, Paul W. McDonald, Kenneth J
To the heart of the APS puzzle
Tumor Necrosis Factor Cell
A Liver Full of JNK: Signaling in Regulation of Cell Function and Disease Pathogenesis, and Clinical Approaches  Ekihiro Seki, David A. Brenner, Michael.
Donor CD3+ lymphocyte infusion after reduced intensity conditioning allogeneic stem cell transplantation: Single-center experience  Jean El-Cheikh, Roberto.
Apoptosis-targeted therapies for cancer
Kinetics and symmetry of divisions of hematopoietic stem cells
Quiescence regulators for hematopoietic stem cell
Eukaryotic Transcription Activation: Right on Target
Volume 152, Issue 1, (January 2013)
Xiaoou Zhou, Malcolm K. Brenner  Experimental Hematology 
Salubrinal reduces expression and activity of MMP13 in chondrocytes
Christopher E. Schmitt, Carlos O. Lizama, Ann C. Zovein 
Experimental Hematology
Susanne Wingert, Michael A. Rieger  Experimental Hematology 
A dual role of Erk signaling in embryonic stem cells
Nanna Fyhrquist, Sampsa Matikainen, Antti Lauerma 
Impact of HDAC inhibitors on dendritic cell functions
Raquel Espín-Palazón, David Traver  Experimental Hematology 
Apoptosis-targeted therapies for cancer
Inside This Issue Experimental Hematology
Sietske T. Bakker, Emmanuelle Passegué  Experimental Hematology 
mTOR Regulation by JNK: Rescuing the Starving Intestinal Cancer Cell?
Pharmacological activation of wild-type p53 in the therapy of leukemia
Kinase signaling and targeted therapy for primary myelofibrosis
A possible mechanism of renal cell death after ischemia/reperfusion
Ashley A. Newcombe, Brenda E.S. Gibson, Karen Keeshan 
Apoptosis: Current Biology
Components and outcomes of selected TNF-superfamily signalling pathways. Components and outcomes of selected TNF-superfamily signalling pathways. (Left)
Volume 70, Issue 3, Pages (August 2006)
The TNF Receptor 1 Cell Volume 114, Issue 2, Pages (July 2003)
The new kid on the block(ade) of the IGF-1 receptor
Stem cell biology and the plasticity polemic
Adiponectin: good, bad, or just plain ugly?
Sam68 Guest STARs in TNF-α Signaling
Tumor necrosis factor-α in cisplatin nephrotoxicity: A homebred foe?
Volume 36, Issue 4, Pages (April 2012)
Matthew I. Stein, Jiang Zhu, Stephen G. Emerson 
Pediatric leukemia: Moving toward more accurate models
Volume 148, Issue 1, (January 2012)
Presentation transcript:

Tumor necrosis factor α in the onset and progression of leukemia Xiaoxi Zhou, Zhuoya Li, Jianfeng Zhou  Experimental Hematology  Volume 45, Pages 17-26 (January 2017) DOI: 10.1016/j.exphem.2016.10.005 Copyright © 2016 ISEH - International Society for Experimental Hematology Terms and Conditions

Figure 1 TNF-α mediated cell survival. The TNF-α–TNFR1–TRADD–TRAF2–RIP and tmTNF-α–TNFR2–TRAF2 complexes trigger signals leading to activation of the transcriptional factor AP-1 through activation of MAPK kinases and JNK and activation of the transcriptional factor NF-κB through the IKK complex. The tmTNF-α–TNFR2 complex also triggers signals leading to suppression of caspase 9, BAD, and FKHRL1 through activation of the PI3K–Akt pathway and promoting cell survival. Experimental Hematology 2017 45, 17-26DOI: (10.1016/j.exphem.2016.10.005) Copyright © 2016 ISEH - International Society for Experimental Hematology Terms and Conditions

Figure 2 Leukemia cells cross-talk with suppressive immune cells via TNF-α and TNFRs. Experimental Hematology 2017 45, 17-26DOI: (10.1016/j.exphem.2016.10.005) Copyright © 2016 ISEH - International Society for Experimental Hematology Terms and Conditions